Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive
HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.
Drugs
Health
Pharma
Drugs
Medical
Liver regeneration possible with new drug, eliminating need for a transplant
New drug can help activate liver regeneration and repair in end-stage liver disease